FDA Funding Debate Reframed By GAO Reports On Strategic Planning
This article was originally published in The Pink Sheet Daily
Executive Summary
Republican senators argue reports show that FDA needs significant reform; discussion of Cures and User Fee legislation will now likely focus on what the plan should be.